Federated Hermes’s Anavex Life Sciences AVXL Stock Holding History

Federated Hermes’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.78M	Buy	1,071,809 +539,557	+101%	+$1.6M	﹤0.01%	959
2026 Q1	$1.63M	Buy	532,252 +164,411	+45%	+$712K	﹤0.01%	1006
2025 Q4	$1.31M	Buy	+367,841	New	+$2.25M	﹤0.01%	1057
2025 Q3	–	Sell	-130	Closed	-$1.2K	–	2125
2025 Q2	$1.2K	Buy	+130	New	+$1.11K	﹤0.01%	1991
2021 Q3	–	Sell	-35,527	Closed	-$812K	–	2213
2021 Q2	$812K	Buy	35,527 +17,753	+100%	+$263K	﹤0.01%	1377
2021 Q1	$266K	Buy	+17,774	New	+$194K	﹤0.01%	1666
2017 Q2	–	Sell	-247	Closed	-$1K	–	2123
2017 Q1	$1K	Buy	+247	New	+$1.28K	﹤0.01%	2054

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Federated Hermes's AVXL Position: Q2 2026 in Review

Federated Hermes increased its Anavex Life Sciences (AVXL) stake by 101% in Q2 2026, buying an estimated $1.6M and bringing the position to 1,071,809 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #959.

Federated Hermes first reported a position in AVXL in Q1 2017 and has held it in 7 quarters since. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

Federated Hermes held 1,071,809 shares of Anavex Life Sciences worth $2.78M as of Q2 2026.
Federated Hermes bought 539,557 Anavex Life Sciences shares in Q2 2026, an estimated $1.6M.
Anavex Life Sciences made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #959 holding.
Federated Hermes first reported a position in Anavex Life Sciences in Q1 2017 and has held it in 7 quarters since.
179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.